Skip to main content
Caplight Logo









Zelegent, Inc.

Zelegent, Inc.

Private
Newport Beach, CaliforniaHealthcare & Life Scienceshttps://zelegent.com

Last Round

Early Funding

Oct 19, 2020

Total Funding Raised

$2.14M

Company Overview

Zelegent, Inc. is a medical technology company that develops and commercializes minimally-invasive devices for the treatment of snoring and sleep-disordered breathing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicesnoring treatmentminimally invasive surgeryotolaryngologyENToffice-based proceduresoft palatesleep medicinesnoring curepalatal fluttersuture implantsleep apnea devicenon-surgical snoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zelegent, Inc. Comparables

Compare Zelegent, Inc. with similar companies based on industry and business-model similarity.

Zelegent, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Serene Sleep
89%
Medtronic
75%
Aerin Medical
73%

Zelegent, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 19, 2020
Series ADec 15, 2015

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 19, 2020

    $2.14M raised in early funding.

  • Dec 15, 2015

    Raised Series A round led by AEON Biopharma Inc.

Zelegent, Inc. Filings

Explore SEC and related filing metadata, where available.

Zelegent, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zelegent, Inc.'s valuation, stock price, and market status.

Is Zelegent, Inc. a public or private company?

Zelegent, Inc. is a private company.

What is the current stock price of Zelegent, Inc.?

Zelegent, Inc. is a private company with no public stock price. Caplight tracks Zelegent, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Zelegent, Inc. worth (valuation)?

Valuation information for Zelegent, Inc. is not publicly available.

Can I buy Zelegent, Inc. stock?

Zelegent, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zelegent, Inc.'s last funding round?

Zelegent, Inc.'s most recent funding round was Early Funding on October 19, 2020.

Who are the main investors in Zelegent, Inc.?

Investor information for Zelegent, Inc. is not publicly disclosed.

Will Zelegent, Inc. IPO soon?

No public IPO plans have been announced for Zelegent, Inc..

How can I track Zelegent, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zelegent, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewport Beach, California
Year Founded2015
Last FundingOct 19, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?